International Biotechnology Trust PLC Gilead Sciences, Inc. Transaction History

International Biotechnology Trust PLC

$295 Million
Q3 2023

A detailed history of International Biotechnology Trust PLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, International Biotechnology Trust PLC holds 233,584 shares of GILD stock, worth $21.5 Million. This represents 5.94% of its overall portfolio holdings.

Number of Shares

233,584

Previous 144,584 61.56%

Holding current value

$21.5 Million

Previous $11.1 Million 57.09%

% of portfolio

5.94%

Previous 3.47%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$73.94 - $80.67 $6.58 Million - $7.18 Million	89,000 Added 61.56%	233,584 $17.5 Million
Q2 2023 Aug 08, 2023	BUY	$76.01 - $86.7 $6.61 Million - $7.54 Million	87,000 Added 151.08%	144,584 $11.1 Million
Q4 2022 Feb 01, 2023	SELL	$62.32 - $89.47 $9.42 Million - $13.5 Million	-151,200 Reduced 72.42%	57,584 $4.94 Million
Q3 2022 Nov 08, 2022	BUY	$59.54 - $68.01 $11.9 Million - $13.6 Million	199,772 Added 2216.73%	208,784 $12.9 Million
Q2 2022 Aug 16, 2022	SELL	$57.72 - $65.01 $4.6 Million - $5.19 Million	-79,772 Reduced 89.85%	9,012 $146 Million
Q1 2022 May 20, 2022	SELL	$57.92 - $72.58 $11.2 Million - $14.1 Million	-194,000 Reduced 68.6%	88,784 $5.28 Million
Q4 2021 Feb 15, 2022	SELL	$64.88 - $73.64 $7.79 Million - $8.84 Million	-120,000 Reduced 29.79%	282,784 $20.5 Million
Q2 2021 Aug 11, 2021	BUY	$63.47 - $69.35 $952,050 - $1.04 Million	15,000 Added 3.87%	402,784 $27.7 Million
Q1 2021 May 17, 2021	BUY	$60.0 - $68.46 $2.37 Million - $2.7 Million	39,500 Added 11.34%	387,784 $25.1 Million
Q4 2020 Feb 19, 2021	BUY	$56.65 - $64.55 $1.53 Million - $1.74 Million	27,000 Added 8.4%	348,284 $20.3 Million
Q3 2020 Dec 01, 2020	BUY	$62.1 - $78.08 $1.12 Million - $1.41 Million	18,000 Added 5.94%	321,284 $20.3 Million
Q2 2020 Jul 14, 2020	BUY	$72.34 - $84.0 $4.77 Million - $5.54 Million	66,000 Added 27.81%	303,284 $22.6 Million
Q1 2020 May 18, 2020	SELL	$62.63 - $80.22 $3.51 Million - $4.49 Million	-56,000 Reduced 19.09%	237,284 $17.7 Million
Q4 2019 May 18, 2020	SELL	$61.62 - $67.78 $1.42 Million - $1.56 Million	-23,000 Reduced 7.27%	293,284 $19.1 Million
Q2 2019 Aug 14, 2019	BUY	$61.87 - $69.38 $2.35 Million - $2.64 Million	38,000 Added 13.66%	316,284 $21.4 Million
Q1 2019 May 14, 2019	BUY	$62.53 - $70.05 $4.06 Million - $4.55 Million	65,000 Added 30.48%	278,284 $18.1 Million
Q4 2018 Feb 14, 2019	BUY	$60.54 - $79.0 $7.45 Million - $9.72 Million	123,000 Added 136.24%	213,284 $10.5 Million
Q3 2018 Nov 14, 2018	SELL	$71.28 - $78.92 $7.82 Million - $8.66 Million	-109,716 Reduced 54.86%	90,284 $5.35 Million
Q3 2018 Nov 13, 2018	BUY	$71.28 - $78.92 $7.82 Million - $8.66 Million	109,716 Added 121.52%	200,000 $10.6 Million
Q2 2018 Aug 13, 2018	SELL	$64.88 - $75.68 $2.66 Million - $3.1 Million	-41,000 Reduced 31.23%	90,284 $6.4 Million
Q1 2018 May 15, 2018	BUY	$72.84 - $88.8 $619,140 - $754,800	8,500 Added 6.92%	131,284 $9.9 Million
Q3 2017 Mar 02, 2018	BUY	$72.11 - $85.47 $72,110 - $85,470	1,000 Added 0.82%	122,784 $9.95 Million
Q2 2017 Mar 02, 2018	BUY	N/A	20,000 Added 19.65%	121,784 $8.62 Million
Q1 2017 Mar 02, 2018	SELL	N/A	-74,000 Reduced 42.1%	101,784 $6.91 Million
Q4 2016 Mar 02, 2018	BUY	N/A	175,784	175,784 $12.6 Million

Others Institutions Holding GILD

# of Institutions

1,926

Shares Held

992M

Call Options Held

10.5M

Put Options Held

9.75M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $115B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of International Biotechnology Trust PLC, based on Form 13F filings with the SEC.

News

Stay updated on International Biotechnology Trust PLC with notifications on news.

Account

International Biotechnology Trust PLC Gilead Sciences, Inc. Transaction History